D -- Notice of Intent - Drug Utilization Database

The U.S. Food and Drug Administration (FDA) intends to award, using Simplified Acquisition Procedures, in accordance with FAR Part 13, a sole source modification to Premier, Inc., 2320 Cascade Point Blvd, Charlotte, NC 28208-6880, under authority of FAR 6.302-1 41 U.SC. 253 ( C )( 1 ) which states that only one responsible source and no other supplies or services will satisfy agency requirements. The Government anticipates the issuance of a Modification within (5) days after the response date of this notice. It is anticipated that the period of performance will be April 3, 2008 through September 28, 2012 including option periods and the total amount of the contract period including options is $1.5M. The contractor currently provides the FDA the ability to access inpatient drug utilization data through Premier?s Perspective? inpatient claims database and will be required to provide validation studies (including medical chart abstractions), feasibility studies, customized analysis, projection methodology studies, risk management studies, concomitant drug studies and, additional training sessions for FDA employees. Premier?s data is now being used both in the initial investigations and assessments nationwide by the FDA. All responsible sources may submit a response by the due date of this posting to contact@example.gov and all questions regarding the post should be sent to the same e-mail address. Responses must be received within eight days from the published date of this notice. All responses must be sent electronically, no faxes will be accepted.